Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Hepatology
•
Hepatology
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
Related Questions
What is your approach to a patient with an elevated alkaline phosphatase level, but negative PBC serologies and normal biliary imaging?
Do you always consider ADPCKD or ARPCKD in a patient who is incidentally found to have liver and renal cysts?
How do you incorporate palliative care specialists into the care of patients with chronic liver disease, especially those who may not be transplant candidates?
How do you approach a patient who has incidentally found liver and renal cysts?
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
What testing do you utilize to decide a patient's candidacy for Resmetirom therapy?
How do you approach treatment options for patients with fibrolamellar HCC compared to "normal" HCC?
How do you approach a patient with discordant Fibroscan and serologic testing for fibrosis?
How do you determine when you would treat an identified spleno-renal shunt and how?
